In Re Regulus Therapeutics Inc. Securities Litigation

Good Law
United States District Court, Southern District of CaliforniaOctober 30, 20203:17-cv-00182California5,524 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 IN RE REGULUS Case No.: 3:17-cv-182-BTM-RBB THERAPEUTICS INC. Case No.: 3:17-cv-267-BTM-RBB

SECURITIES LITIGATION

ORDER GRANTING FINAL

APPROVAL OF SETTLEMENT

14 . AND ATTORNEYS’ FEES 15 [ECF NOS. 46, 47]

17 The Court previously granted a motion for preliminary approval of the parties' 18 Class Action Settlement in this matter on May 27, 2020. (ECF No. 43.) As directed 19 by the Court's preliminary approval order, Plaintiffs filed their unopposed motion 20 for final settlement approval and motion for attorneys’ fees and costs. (ECF Nos. 21 46, 48.) The Court held a hearing on October 21, 2020. (ECF No. 52.) 22 Having considered the motion briefing, the terms of the Settlement 23 Agreement, the lack of any objections, the arguments of counsel, and the other 24 matters on file in this action, the Court GRANTS the motions for final approval and 25 attorneys’ fees and costs.

27 28 I. BACKGROUND A. Procedural History…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.